disopyramide has been researched along with Atrioventricular Nodal Reentrant Tachycardia in 3 studies
Disopyramide: A class I anti-arrhythmic agent (one that interferes directly with the depolarization of the cardiac membrane and thus serves as a membrane-stabilizing agent) with a depressant action on the heart similar to that of guanidine. It also possesses some anticholinergic and local anesthetic properties.
disopyramide : A monocarboxylic acid amide that is butanamide substituted by a diisopropylamino group at position 4, a phenyl group at position 2 and a pyridin-2-yl group at position 2. It is used as a anti-arrhythmia drug.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We evaluated the electrophysiological mechanisms of adverse effects of class I antiarrhythmic drugs (cibenzoline in seven patients, pilsicainide in two, and disopyramide in two, and procainamide in three) in the induction of orthodromic atrioventricular re-entrant tachycardia (AVRT)." | 2.68 | Electrophysiologic mechanisms of adverse effects of class I antiarrhythmic drugs (cibenzoline, pilsicainide, disopyramide, procainamide) in induction of atrioventricular re-entrant tachycardia. ( Fujiki, A; Inoue, H; Tani, M; Yoshida, S, 1996) |
| "Antiarrhythmic therapy was chosen for 3-7 days by modified chronic electrophysiological study at three stages: (1) the efficacy of a drug, its action onset and termination were defined; (2) a dosage was chosen on an individual basis and the duration of drug potency was specified; (3) the dosage regimen of a drug given as a course therapy was confirmed by the results of trials." | 2.67 | [Evaluation of the possibility of selection of individual anti-arrhythmia therapy]. ( Antonchenko, IV; Borisova, EV; Chekhov, AM; Gimrikh, EO; Plekhanov, IG; Popov, SV; Savenkova, GM, 1991) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fujiki, A | 1 |
| Tani, M | 1 |
| Yoshida, S | 1 |
| Inoue, H | 1 |
| Antonchenko, IV | 1 |
| Gimrikh, EO | 1 |
| Popov, SV | 1 |
| Chekhov, AM | 1 |
| Borisova, EV | 1 |
| Savenkova, GM | 1 |
| Plekhanov, IG | 1 |
| Grishkin, IuN | 1 |
2 trials available for disopyramide and Atrioventricular Nodal Reentrant Tachycardia
| Article | Year |
|---|---|
Electrophysiologic mechanisms of adverse effects of class I antiarrhythmic drugs (cibenzoline, pilsicainide, disopyramide, procainamide) in induction of atrioventricular re-entrant tachycardia.
Topics: Adolescent; Adult; Aged; Anti-Arrhythmia Agents; Disopyramide; Electrophysiology; Female; Heart Cond | 1996 |
[Evaluation of the possibility of selection of individual anti-arrhythmia therapy].
Topics: Adolescent; Adult; Anti-Arrhythmia Agents; Atrial Fibrillation; Disopyramide; Humans; Middle Aged; P | 1991 |
1 other study available for disopyramide and Atrioventricular Nodal Reentrant Tachycardia
| Article | Year |
|---|---|
[Effect of ritmilen on myocardial refractility and cardiac impulse conduction in patients with paroxysmal tachycardia].
Topics: Adult; Aged; Anti-Arrhythmia Agents; Disopyramide; Heart Atria; Heart Conduction System; Heart Ventr | 1991 |